Le Lézard
Classified in: Business
Subjects: NPT, FOR, TRD

Turkish Heritage Organization Expands Advisory Board

WASHINGTON, July 1, 2015 /PRNewswire-USNewswire/ -- The Turkish Heritage Organization (THO) announced today the expansion of its Advisory Board to include four specialists in international and U.S.-Turkey relations. Joining the THO are Andrew Bacevich of Boston University, Michael Gunter of Tennessee Technological University, Robert Olson of the University of Kentucky, and Edward Erickson of the Marine Corps University. These experts bring important perspectives to the issues most important to the THO ? from trade and energy to security and humanitarian issues.

Turkish Heritage Organization Logo

Andrew J. Bacevich, Professor of History and International Relations emeritus at Boston University, brings to the THO Advisory Board a deep understanding of the history of American diplomacy in the region. His expertise on American militarism and foreign policy will further complement the Advisory Board with a U.S. perspective on Turkish issues.

The THO also welcomes contributors to the establishment of Kurdish studies in the U.S. to its Advisory Board. Michael M. Gunter, Professor of Political Science at Tennessee Technological University and Secretary-General of the EU Turkey Civic Commission (EUTCC), has taught and written extensively about Middle Eastern politics, particularly Kurdish politics. He joins colleague Robert Olson, Professor Emeritus of Middle East History and Politics at the University of Kentucky, also a specialist in Kurdish Studies and the co-author with Gunter of numerous books and essays.

A fourth addition to the Advisory Board is Dr. Edward Erickson, Professor of Military History at the Command and Staff College, Marine Corps University. Dr. Erickson brings a unique view to the THO, having served three tours in Turkey as a Foreign Area Officer with the U.S. Army.

"We are delighted to have members with such extensive knowledge on Turkey and the Middle East region and we are very grateful that these researchers have lent their expertise to the THO," said Halil Danismaz, President of the THO. "I am certain our Board will continue to provide exceptional insight to the issues that we care about and about the future of U.S.-Turkey relations."

For more information on THO and its experts, visit TurkHeritage.org and follow @TurkHeritage.

The Turkish Heritage Organization (THO) is a non-profit organization founded to promote discussion and dialogue around issues of importance in the U.S.-Turkey bilateral relationship and Turkey's role in the international community.

Logo - http://photos.prnewswire.com/prnh/20150423/201251LOGO

SOURCE Turkish Heritage Organization

These press releases may also interest you

at 18:03
Saputo Inc. ("Saputo") completed today the transaction announced on November 1, 2017 and acquired Betin, Inc., doing business as Montchevre. Its activities are conducted at one manufacturing facility located in Belmont, Wisconsin (USA). The business...

at 17:49
Sinclair Broadcast Group, Inc. ("Sinclair" or the "Company") announced today that its wholly-owned subsidiary, Sinclair Television Group, Inc. ("STG"), has raised new incremental term B loans and amended certain terms under its existing bank credit...

at 17:44
On December 12, 2017, the Commission issued a Notice of Hearing pursuant to Sections 104 and 127 of the Securities Act, RSO 1990, c S.5 to consider the Amended Application filed by CanniMed Therapeutics Inc. ("CanniMed") dated December 11, 2017, in...

at 17:33
HARTE GOLD CORP. ("Harte Gold") is pleased to announce a Bought Deal Private Placement (the "Offering") of approximately 55.3 million common shares at C$0.47 per common share and approximately 1.8 million flow through common shares at C$0.56 per...

at 17:26
TSX VENTURE COMPANIES ALTURAS MINERALS CORP. ("ALT")BULLETIN TYPE:  Shares for DebtBULLETIN DATE: December 12, 2017TSX Venture Tier 1 Company TSX Venture Exchange has accepted for filing the Company's proposal to issue 16,522,865 shares to settle...

at 17:22
ESSA Pharma Inc. ("ESSA" or the "Company"), a pre-clinical stage pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, is pleased to announce that today it has undertaken an overnight...

News published on 1 july 2015 at 13:15 and distributed by: